Vardhanabhuti, Saran

Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. [electronic resource] - Open forum infectious diseases Sep 2015 - ofv085 p. digital

Publication Type: Journal Article

2328-8957

10.1093/ofid/ofv085 doi